Article info
Clinical science
Adalimumab for the treatment of refractory active and inactive non-infectious uveitis
- Correspondence to Associate Professor Lyndell L Lim, Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC 3002, Australia; limllp{at}unimelb.edu.au
Citation
Adalimumab for the treatment of refractory active and inactive non-infectious uveitis
Publication history
- Received August 23, 2017
- Revised January 25, 2018
- Accepted January 31, 2018
- First published February 19, 2018.
Online issue publication
November 23, 2018
Article Versions
- Previous version (22 November 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.